4//SEC Filing
Selman Renee 4
Accession 0001104659-17-054006
CIK 0001261249other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:31 PM ET
Size
4.9 KB
Accession
0001104659-17-054006
Insider Transaction Report
Form 4
Selman Renee
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2017-08-25$3.35/sh+7,250$24,288→ 60,583 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $3.345 to $3.349, inclusive. The reporting person undertakes to provide to Agile Therapeutics, Inc., any security holder of Agile Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
AGILE THERAPEUTICS INC
CIK 0001261249
Entity typeother
Related Parties
1- filerCIK 0001677942
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:31 PM ET
- Size
- 4.9 KB